Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Articles tagged with "ACR/ARHP Annual Meeting"

Rheumatoid Arthritis Drugs May Cut Cardiovascular Risk

Kathleen Louden  |  April 6, 2012

Other studies at the ACR/ARHP Annual Scientific Meeting in November examined arthritis treatment, scleroderma screening.

Pinpoint Cognitive Dysfunction in Patients with Lupus

Vanessa Caceres  |  April 6, 2012

More than 80% of SLE patients experience some type of neurologic manifestation during their disease course. The challenge for rheumatologists and other clinicians lies in appropriately diagnosing any cognitive dysfunctions that accompany lupus and better understanding the causes and risk factors of those dysfunctions. “Cognitive Function in SLE” was the focus of a talk at the 2011 ACR/ARHP Annual Scientific Meeting in November.

Biosimilar Drugs Face Challenges to Reach the U.S. Market

Kathleen Louden  |  March 8, 2012

To date, the FDA has not approved a biosimilar product. In its own discussion of the merits and obstacles to biosimilar drugs, the ACR sponsored a panel session titled, “Biosimilar Products in the U.S. Market: Fact or Fiction?” at the 2011 ACR/ARHP Annual Scientific Meeting here in November.

Where Will Kinase Inhibitors Fit into the RA Treatment Mix?

Vanessa Caceres  |  March 8, 2012

Presenters at “Looking Ahead to Kinase Inhibition in Rheumatoid Arthritis,” a session here at the 2011 ACR/ARHP Annual Scientific Meeting, delved into some of the big questions that rheumatology faces with kinase inhibitor use.

Link between Autoimmunity and Environmental Exposure Needs Further Research

Vanessa Caceres  |  March 8, 2012

Rheumatology needs further cost-effective and validated methods to track the connection between environmental exposure and autoimmune diseases, including research on phenotypes, genotypes, the synergy between multiple infectious and noninfectious exposures, the timing of exposure, and the mechanisms involved, according to presenters of “Impact of Environmental Health on Autoimmunity,” a session here at the 2011 ACR/ARHP Annual Scientific Meeting held in Chicago in November 2011.

New Diagnostic Criteria for Axial Spondylarthritis

Ann Kepler  |  February 3, 2012

New name and classification criteria for ankylosing spondylitis may help with earlier diagnosis and treatment.

ACR Volunteers Attend Leadership Development Conference

Staff  |  February 3, 2012

Last month, volunteers from the ACR, ARHP, and REF met in Atlanta for the Annual Leadership Development Conference. This year’s conference focused on media relations and social media in a healthcare environment. The goal of this year’s conference was to educate the volunteers on how to successfully use the different types of media outreach. The topics were timely, what with the launch of the ACR’s first public relations campaign, Simple Tasks, and a successful social media session held at the 2011 ACR/ARHP Annual Scientific Meeting.

Shortcomings and Promises of Genome-wide Association Studies

Ann Kepler  |  February 3, 2012

The outcomes of genome-wide association studies (GWAS) have not been what scientists expected, but researchers are developing new approaches to use revelatory GWAS information to identify genetic causal variants, predictors of treatment response, and future opportunities for genetic insight.

Welcome New ACR and ARHP Leaders

Staff  |  January 13, 2012

The ACR is pleased to continue its welcome of the newest members of the ACR board of directors and ARHP executive committee. These new members were confirmed last November during the ACR/ARHP Annual Scientific Meeting in Chicago. In the December 2011 “From the College,” we introduced you to several new members (“Welcome New ACR and ARHP Leaders,”). In this issue, you will meet the rest of the new members joining the leadership ranks and learn what they want to gain from their experience as new board and executive committee members.

Incoming ACR Volunteers

Staff  |  January 13, 2012

Karen Kolba, MD and Robert A. Colbert, MD, PhD

  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 24
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences